Moreover, drugs that inhibit AKT or STAT3, such as MK-2206 or Niclosamide, did not affect the viability of T-ALL and B-ALL cells (Supplementary Fig. S15c). Here, AKT1 is linked to acute lymphoblastic leukemia.